An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions
暂无分享,去创建一个
M. D’Elios | E. Silvestri | G. Emmi | V. Pengo | D. Prisco | G. Denas | L. Ciucciarelli | A. Cameli | D. Squatrito | L. Emmi
[1] Yulia Einav,et al. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. , 2014, Autoimmunity reviews.
[2] E. Silvestri,et al. Anti-TNF-α agents in vascular Behçet's disease , 2014, Expert review of cardiovascular therapy.
[3] R. Cervera,et al. Renal Involvement in Antiphospholipid Syndrome , 2014, Current Rheumatology Reports.
[4] N. Hill,et al. Primary antiphospholipid syndrome and pulmonary hypertension. , 2014, Current pharmaceutical design.
[5] D. Boumpas,et al. Pathogenesis and treatment of CNS lupus , 2013, Current opinion in rheumatology.
[6] M. Khamashta,et al. Seronegative antiphospholipid syndrome. , 2013, Rheumatology.
[7] J. Alijotas-Reig,et al. Current Concepts and New Trends in the Diagnosis and Management of Recurrent Miscarriage , 2013, Obstetrical & gynecological survey.
[8] G. Vaiopoulos,et al. The lung in the spectrum of antiphospholipid syndrome. , 2013, Clinical and experimental rheumatology.
[9] K. Heimdal,et al. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[10] O. Sedrati,et al. Le syndrome de Sneddon , 2013 .
[11] G. Remuzzi,et al. STEC-HUS, atypical HUS and TTP are all diseases of complement activation , 2012, Nature Reviews Nephrology.
[12] I. Martinelli,et al. Cerebral sinus-venous thrombosis , 2012, Internal and Emergency Medicine.
[13] M. D’Elios,et al. Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle. , 2012, Clinical and experimental rheumatology.
[14] M. Papadopoulos,et al. Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.
[15] D. Gillis,et al. Rarer Clinical Associations of Antiphospholipid Antibodies , 2012, Seminars in Thrombosis & Hemostasis.
[16] R. Podemski,et al. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis , 2012, Lupus.
[17] Y. Shoenfeld,et al. HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. , 2011, Seminars in arthritis and rheumatism.
[18] P. D. de Groot,et al. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment , 2011, Journal of internal medicine.
[19] G. Zlatanović,et al. Anticardiolipin antibodies in patients with Behcet's disease. , 2011, Bosnian journal of basic medical sciences.
[20] S. Dean. Livedo Reticularis and Related Disorders , 2011, Current treatment options in cardiovascular medicine.
[21] I. Uthman,et al. Antiphospholipid Syndrome: Endocrinologic Manifestations and Organ Involvement , 2011, Seminars in thrombosis and hemostasis.
[22] C. Francès. Dermatological manifestations of Hughes’ antiphospholipid antibody syndrome , 2010, Lupus.
[23] S. Colagrande,et al. Devic’s syndrome and primary APS: a new immunological overlap , 2010, Lupus.
[24] Drew Provan,et al. International consensus report on the investigation and management of primary immune thrombocytopenia. , 2010, Blood.
[25] M. Tektonidou. Renal Involvement in the Antiphospholipid Syndrome (APS)—APS Nephropathy , 2009, Clinical reviews in allergy & immunology.
[26] Y. Shoenfeld,et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". , 2009, Journal of autoimmunity.
[27] V. Valtchev,et al. SNEDDON'S SYNDROME , 2009 .
[28] R. Mantilla,et al. Osteonecrosis and antiphospholipid syndrome. , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[29] D. Kidd,et al. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management , 2009, The Lancet Neurology.
[30] B. Chong,et al. Heparin-induced thrombocytopenia: What clinicians need to know , 2009, Thrombosis and Haemostasis.
[31] H. Glimm,et al. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up , 2008, Lupus.
[32] J. Walenga,et al. The Laboratory Diagnosis and Clinical Management of Patients with Heparin-Induced Thrombocytopenia: An Update , 2008, Seminars in thrombosis and hemostasis.
[33] A. Silman,et al. EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.
[34] C. D. di Gioia,et al. Dilated Cardiomyopathy Due to Thrombotic Microangiopathy as the only Manifestation of Antiphospholipid Syndrome: A Case Report , 2008, International journal of immunopathology and pharmacology.
[35] M. Khamashta,et al. The abdominal manifestations of the antiphospholipid syndrome. , 2007, Rheumatology.
[36] L. Stojanovich,et al. Ocular manifestations in antiphospholipid syndrome. , 2007, Autoimmunity reviews.
[37] H. Link,et al. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness , 2006, Journal of Neuroimmunology.
[38] D. D'cruz,et al. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. , 2006, Rheumatic diseases clinics of North America.
[39] Y. Shoenfeld,et al. Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? , 2006, The Journal of rheumatology.
[40] N. Herial,et al. Sneddon's Syndrome , 2006, Cephalalgia : an international journal of headache.
[41] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[42] J. Stam. Thrombosis of the cerebral veins and sinuses. , 2005, The New England journal of medicine.
[43] H. Moutsopoulos,et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. , 2004, Arthritis and rheumatism.
[44] Kevin Barraclough,et al. I and i , 2001, BMJ : British Medical Journal.
[45] F B Taylor,et al. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.
[46] J. Merrill,et al. Catastrophic antiphospholipid syndrome , 2006, Nature Clinical Practice Rheumatology.
[47] M. Khamashta,et al. Can Neurologic Manifestations of Hughes (Antiphospholipid) Syndrome Be Distinguished from Multiple Sclerosis?: Analysis of 27 Patients and Review of the Literature , 2000, Medicine.
[48] P. Lazzarin,et al. Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. , 1990, Annals of the rheumatic diseases.
[49] S. Cutillo. [Hemolytic-uremic syndrome]. , 1973, La Pediatria.
[50] R. Stephenson. A and V , 1962, The British journal of ophthalmology.
[51] M. Wislowska. [Catastrophic antiphospholipid syndrome]. , 2015, Wiadomosci lekarskie.
[52] G. Geri,et al. [Cardiac involvement in antiphospholipid syndrome]. , 2011, Presse medicale.
[53] R. Cervera,et al. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic? , 2008, Autoimmunity reviews.
[54] J. Piette,et al. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. , 2006, Clinical and experimental rheumatology.
[55] J. Stam. current concepts Thrombosis of the Cerebral Veins and Sinuses , 2005 .